Preimplantation genetic testing (PGT) for hemophilia A: Experience from one center

Objective: Hemophilia A (HA) is an X-linked recessive bleeding disease caused by a deficiency or dysfunction of blood coagulation factor VIII (FVIII). Available treatment to replenish the missing factor may not reach a good outcome for all patients because of potential complications that include the...

Full description

Bibliographic Details
Main Authors: Thi Minh Phuong Bui, Van Khanh Tran, Thi Thanh Hai Nguyen, Thi Phuong Le, Thi Mai Nguyen, Hai Anh Tran, Vu Dung Luu, Manh Ha Nguyen, The-Hung Bui, Thanh Van Ta, Thinh Huy Tran
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Taiwanese Journal of Obstetrics & Gynecology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1028455922002819
_version_ 1811216328368848896
author Thi Minh Phuong Bui
Van Khanh Tran
Thi Thanh Hai Nguyen
Thi Phuong Le
Thi Mai Nguyen
Hai Anh Tran
Vu Dung Luu
Manh Ha Nguyen
The-Hung Bui
Thanh Van Ta
Thinh Huy Tran
author_facet Thi Minh Phuong Bui
Van Khanh Tran
Thi Thanh Hai Nguyen
Thi Phuong Le
Thi Mai Nguyen
Hai Anh Tran
Vu Dung Luu
Manh Ha Nguyen
The-Hung Bui
Thanh Van Ta
Thinh Huy Tran
author_sort Thi Minh Phuong Bui
collection DOAJ
description Objective: Hemophilia A (HA) is an X-linked recessive bleeding disease caused by a deficiency or dysfunction of blood coagulation factor VIII (FVIII). Available treatment to replenish the missing factor may not reach a good outcome for all patients because of potential complications that include the development of inhibitor antibodies directed against factor VIII. Therefore, the prevention of transmitting pathogenic mutations to the next generation is the best solution for this disease. Preimplantation genetic testing for a monogenic disorder (PGT-M) has become a standard method to prevent the transmission of monogenic heritable disease. The gold standard of the molecular technique used for PGT-M nowadays is the co-amplification of the polymorphic microsatellite linkage markers that use microsatellite DNA technique that overcomes the limitation of other methods. The important issue of this technique is the definition of markers that are specific for each allele on different loci. Each gene locus needs a characteristic design to allow accurate diagnosis that can be applied on PGT-M due to the limited quantity of DNA available. Here we present our study of four specific self-designed linked polymorphic markers applied on screening the embryos before implantation for hemophilia A families in Vietnam. Material and methods: In this study, we investigated the feasibility of application and diagnostic value of 4 STR loci (FXS1108, DXS9897, F8int22, DXS9901) in the intragenic or neighbouring regions of the F8 gene. 35 hemophilia A families were recruited for STR analysis to define at least two characteristic heterologous markers for each family and 12 cases of pre-implantation genetic testing (PGT-M) for carrier mothers were performed. Result: All 4 of these loci (FXS1108, DXS9897, F8int22, DXS9901) were found practical and useful for preimplantation genetic testing (PGT-M). All 12 cases of PGT-M using the method had informative STR results and correct diagnosis was achieved. 9 out of the 12 mothers (75%) were implanted with 1–2 thawed embryos after the biopsy resulting in the birth of 5 healthy babies (55%). Conclusion: We conclude that specific 4 STR markers for rapid pre-implantation genetic testing of hemophilia A can be successfully applied with high confidence and accuracy in clinical settings. The results of the study provide solid evidence confirming that the microsatellite DNA technique is a highly reliable method, suitable for hemophilia A families wishing to determine carrier status or having healthy babies.
first_indexed 2024-04-12T06:37:21Z
format Article
id doaj.art-d37e2a63a61e4e1da8201b46278843f0
institution Directory Open Access Journal
issn 1028-4559
language English
last_indexed 2024-04-12T06:37:21Z
publishDate 2022-11-01
publisher Elsevier
record_format Article
series Taiwanese Journal of Obstetrics & Gynecology
spelling doaj.art-d37e2a63a61e4e1da8201b46278843f02022-12-22T03:43:51ZengElsevierTaiwanese Journal of Obstetrics & Gynecology1028-45592022-11-0161610091014Preimplantation genetic testing (PGT) for hemophilia A: Experience from one centerThi Minh Phuong Bui0Van Khanh Tran1Thi Thanh Hai Nguyen2Thi Phuong Le3Thi Mai Nguyen4Hai Anh Tran5Vu Dung Luu6Manh Ha Nguyen7The-Hung Bui8Thanh Van Ta9Thinh Huy Tran10Hanoi Medical University, Hanoi, Viet Nam; Thai Binh University of Medicine and Pharmacy, Ho Chi Minh City, Viet NamHanoi Medical University, Hanoi, Viet NamHanoi Medical University Hospital, Hanoi Medical University, Hanoi, Viet NamHanoi Medical University, Hanoi, Viet NamNational Institute of Hematology and Blood Transfusion, Hanoi, Viet NamHanoi Medical University, Hanoi, Viet NamHanoi Medical University, Hanoi, Viet Nam; Hai Phong Hospital of Obstetrics and Gynecology, Hai Phong, Viet NamHanoi Medical University, Hanoi, Viet NamHanoi Medical University, Hanoi, Viet Nam; Center for Molecular Medicine, Clinical Genetics Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, SwedenHanoi Medical University, Hanoi, Viet Nam; Hanoi Medical University Hospital, Hanoi Medical University, Hanoi, Viet NamHanoi Medical University, Hanoi, Viet Nam; Hanoi Medical University Hospital, Hanoi Medical University, Hanoi, Viet Nam; Corresponding author. Center for Gene and Protein Research, Hanoi Medical University No 1 Ton That Tung Street, Hanoi 10000, Viet Nam. Fax: +84 2438525115.Objective: Hemophilia A (HA) is an X-linked recessive bleeding disease caused by a deficiency or dysfunction of blood coagulation factor VIII (FVIII). Available treatment to replenish the missing factor may not reach a good outcome for all patients because of potential complications that include the development of inhibitor antibodies directed against factor VIII. Therefore, the prevention of transmitting pathogenic mutations to the next generation is the best solution for this disease. Preimplantation genetic testing for a monogenic disorder (PGT-M) has become a standard method to prevent the transmission of monogenic heritable disease. The gold standard of the molecular technique used for PGT-M nowadays is the co-amplification of the polymorphic microsatellite linkage markers that use microsatellite DNA technique that overcomes the limitation of other methods. The important issue of this technique is the definition of markers that are specific for each allele on different loci. Each gene locus needs a characteristic design to allow accurate diagnosis that can be applied on PGT-M due to the limited quantity of DNA available. Here we present our study of four specific self-designed linked polymorphic markers applied on screening the embryos before implantation for hemophilia A families in Vietnam. Material and methods: In this study, we investigated the feasibility of application and diagnostic value of 4 STR loci (FXS1108, DXS9897, F8int22, DXS9901) in the intragenic or neighbouring regions of the F8 gene. 35 hemophilia A families were recruited for STR analysis to define at least two characteristic heterologous markers for each family and 12 cases of pre-implantation genetic testing (PGT-M) for carrier mothers were performed. Result: All 4 of these loci (FXS1108, DXS9897, F8int22, DXS9901) were found practical and useful for preimplantation genetic testing (PGT-M). All 12 cases of PGT-M using the method had informative STR results and correct diagnosis was achieved. 9 out of the 12 mothers (75%) were implanted with 1–2 thawed embryos after the biopsy resulting in the birth of 5 healthy babies (55%). Conclusion: We conclude that specific 4 STR markers for rapid pre-implantation genetic testing of hemophilia A can be successfully applied with high confidence and accuracy in clinical settings. The results of the study provide solid evidence confirming that the microsatellite DNA technique is a highly reliable method, suitable for hemophilia A families wishing to determine carrier status or having healthy babies.http://www.sciencedirect.com/science/article/pii/S1028455922002819Preimplantation genetic testingHemophilia AMutation detection
spellingShingle Thi Minh Phuong Bui
Van Khanh Tran
Thi Thanh Hai Nguyen
Thi Phuong Le
Thi Mai Nguyen
Hai Anh Tran
Vu Dung Luu
Manh Ha Nguyen
The-Hung Bui
Thanh Van Ta
Thinh Huy Tran
Preimplantation genetic testing (PGT) for hemophilia A: Experience from one center
Taiwanese Journal of Obstetrics & Gynecology
Preimplantation genetic testing
Hemophilia A
Mutation detection
title Preimplantation genetic testing (PGT) for hemophilia A: Experience from one center
title_full Preimplantation genetic testing (PGT) for hemophilia A: Experience from one center
title_fullStr Preimplantation genetic testing (PGT) for hemophilia A: Experience from one center
title_full_unstemmed Preimplantation genetic testing (PGT) for hemophilia A: Experience from one center
title_short Preimplantation genetic testing (PGT) for hemophilia A: Experience from one center
title_sort preimplantation genetic testing pgt for hemophilia a experience from one center
topic Preimplantation genetic testing
Hemophilia A
Mutation detection
url http://www.sciencedirect.com/science/article/pii/S1028455922002819
work_keys_str_mv AT thiminhphuongbui preimplantationgenetictestingpgtforhemophiliaaexperiencefromonecenter
AT vankhanhtran preimplantationgenetictestingpgtforhemophiliaaexperiencefromonecenter
AT thithanhhainguyen preimplantationgenetictestingpgtforhemophiliaaexperiencefromonecenter
AT thiphuongle preimplantationgenetictestingpgtforhemophiliaaexperiencefromonecenter
AT thimainguyen preimplantationgenetictestingpgtforhemophiliaaexperiencefromonecenter
AT haianhtran preimplantationgenetictestingpgtforhemophiliaaexperiencefromonecenter
AT vudungluu preimplantationgenetictestingpgtforhemophiliaaexperiencefromonecenter
AT manhhanguyen preimplantationgenetictestingpgtforhemophiliaaexperiencefromonecenter
AT thehungbui preimplantationgenetictestingpgtforhemophiliaaexperiencefromonecenter
AT thanhvanta preimplantationgenetictestingpgtforhemophiliaaexperiencefromonecenter
AT thinhhuytran preimplantationgenetictestingpgtforhemophiliaaexperiencefromonecenter